|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-11-2
|
|
pubmed:abstractText |
To compare the efficacy and safety of a fixed combination of 2.0% dorzolamide and 0.5% timolol administered twice daily with each of the individual components administered in their usual monotherapy dose regimens in patients who had washed out all ocular hypotensive medications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1945-51
|
|
pubmed:dateRevised |
2008-5-2
|
|
pubmed:meshHeading |
pubmed-meshheading:9787368-Adrenergic beta-Antagonists,
pubmed-meshheading:9787368-Adult,
pubmed-meshheading:9787368-Aged,
pubmed-meshheading:9787368-Aged, 80 and over,
pubmed-meshheading:9787368-Carbonic Anhydrase Inhibitors,
pubmed-meshheading:9787368-Double-Blind Method,
pubmed-meshheading:9787368-Drug Administration Schedule,
pubmed-meshheading:9787368-Drug Therapy, Combination,
pubmed-meshheading:9787368-Female,
pubmed-meshheading:9787368-Glaucoma, Open-Angle,
pubmed-meshheading:9787368-Humans,
pubmed-meshheading:9787368-Intraocular Pressure,
pubmed-meshheading:9787368-Male,
pubmed-meshheading:9787368-Middle Aged,
pubmed-meshheading:9787368-Ocular Hypertension,
pubmed-meshheading:9787368-Ophthalmic Solutions,
pubmed-meshheading:9787368-Safety,
pubmed-meshheading:9787368-Sulfonamides,
pubmed-meshheading:9787368-Thiophenes,
pubmed-meshheading:9787368-Timolol
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
|
|
pubmed:affiliation |
Department of Clinical Research, Merck Research Laboratories, West Point, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Duplicate Publication
|
